Brandon Smith
Direttore operativo presso PROTHENA CORPORATION PLC
Patrimonio netto: - $ in data 31/05/2024
Profilo
Brandon S.
Smith is currently the Chief Operating Officer at Prothena Corp.
Plc.
Prior to his current position, he held the role of Executive Director-Biosimilars Strategy at Amgen, Inc. from 2005 to 2012.
From 2012 to 2017, he served as Senior VP, VP-Corporate Development & Strategy at Impax Laboratories LLC.
Lastly, from 2017 to 2020, he was the Chief Operating Officer at Iconic Therapeutics, Inc. Mr. Smith completed his undergraduate degree at the University of Michigan and holds an MBA from the McCombs School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Brandon Smith
| Società | Posizione | Inizio |
|---|---|---|
| PROTHENA CORPORATION PLC | Direttore operativo | 29/09/2021 |
Precedenti posizioni note di Brandon Smith
| Società | Posizione | Fine |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Direttore operativo | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formazione di Brandon Smith
| University of Michigan | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Brandon Smith
